337 related articles for article (PubMed ID: 33143101)
1. Genetic Susceptibility and Protein Expression of Extracellular Matrix Turnover-Related Genes in Oral Submucous Fibrosis.
Cheng RH; Wang YP; Chang JY; Pan YH; Chang MC; Jeng JH
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143101
[TBL] [Abstract][Full Text] [Related]
2. Oral submucous fibrosis: review on aetiology and pathogenesis.
Tilakaratne WM; Klinikowski MF; Saku T; Peters TJ; Warnakulasuriya S
Oral Oncol; 2006 Jul; 42(6):561-8. PubMed ID: 16311067
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of oral submucous fibrosis.
Khan S; Chatra L; Prashanth SK; Veena KM; Rao PK
J Cancer Res Ther; 2012; 8(2):199-203. PubMed ID: 22842361
[TBL] [Abstract][Full Text] [Related]
4. Areca nut-induced buccal mucosa fibroblast contraction and its signaling: a potential role in oral submucous fibrosis--a precancer condition.
Chang MC; Lin LD; Wu HL; Ho YS; Hsien HC; Wang TM; Jeng PY; Cheng RH; Hahn LJ; Jeng JH
Carcinogenesis; 2013 May; 34(5):1096-104. PubMed ID: 23349021
[TBL] [Abstract][Full Text] [Related]
5. Interaction of collagen-related genes and susceptibility to betel quid-induced oral submucous fibrosis.
Chiu CJ; Chang ML; Chiang CP; Hahn LJ; Hsieh LL; Chen CJ
Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):646-53. PubMed ID: 12101112
[TBL] [Abstract][Full Text] [Related]
6. Oral submucous fibrosis: An update on current theories of pathogenesis.
Arakeri G; Rai KK; Hunasgi S; Merkx MAW; Gao S; Brennan PA
J Oral Pathol Med; 2017 Jul; 46(6):406-412. PubMed ID: 28391620
[TBL] [Abstract][Full Text] [Related]
7. Oral submucous fibrosis: a review article on etiopathogenesis.
Tak J; Gupta N; Bali R
Kathmandu Univ Med J (KUMJ); 2014; 12(46):153-6. PubMed ID: 25552225
[TBL] [Abstract][Full Text] [Related]
8. Areca nut-induced oral fibrosis - Reassessing the biology of oral submucous fibrosis.
Sharma M; Sarode SC; Sarode G; Radhakrishnan R
J Oral Biosci; 2024 Jun; 66(2):320-328. PubMed ID: 38395254
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathogenesis of oral submucous fibrosis--a collagen metabolic disorder.
Rajalalitha P; Vali S
J Oral Pathol Med; 2005 Jul; 34(6):321-8. PubMed ID: 15946178
[TBL] [Abstract][Full Text] [Related]
10. Augmented mRNA expression of tissue inhibitor of metalloproteinase-1 in buccal mucosal fibroblasts by arecoline and safrole as a possible pathogenesis for oral submucous fibrosis.
Shieh DH; Chiang LC; Shieh TY
Oral Oncol; 2003 Oct; 39(7):728-35. PubMed ID: 12907213
[TBL] [Abstract][Full Text] [Related]
11. Panax notoginseng saponins inhibit areca nut extract-induced oral submucous fibrosis in vitro.
Dai JP; Chen XX; Zhu DX; Wan QY; Chen C; Wang GF; Li WZ; Li KS
J Oral Pathol Med; 2014 Jul; 43(6):464-70. PubMed ID: 24484214
[TBL] [Abstract][Full Text] [Related]
12. Why only areca nut chewing cannot cause oral submucous fibrosis?
Sarode SC; Mahuli A; Sarode GS; Mahuli S
Med Hypotheses; 2013 Jul; 81(1):47-9. PubMed ID: 23602208
[TBL] [Abstract][Full Text] [Related]
13. A systematic review on the mechanisms of malignant transformation of oral submucous fibrosis.
Phulari RGS; Dave EJ
Eur J Cancer Prev; 2020 Sep; 29(5):470-473. PubMed ID: 32740174
[TBL] [Abstract][Full Text] [Related]
14. Effect of α-tocopherol on salivary reactive oxygen species and trace elements in oral submucous fibrosis.
Chitra S; Balasubramaniam M; Hazra J
Ann Clin Biochem; 2012 May; 49(Pt 3):262-5. PubMed ID: 22337705
[TBL] [Abstract][Full Text] [Related]
15. Oral mucosal lesions associated with betel quid, areca nut and tobacco chewing habits: consensus from a workshop held in Kuala Lumpur, Malaysia, November 25-27, 1996.
Zain RB; Ikeda N; Gupta PC; Warnakulasuriya S; van Wyk CW; Shrestha P; Axéll T
J Oral Pathol Med; 1999 Jan; 28(1):1-4. PubMed ID: 9890449
[TBL] [Abstract][Full Text] [Related]
16. Effect of betel chewing, tobacco smoking and alcohol consumption on oral submucous fibrosis: a case-control study in Sri Lanka.
Ariyawardana A; Athukorala AD; Arulanandam A
J Oral Pathol Med; 2006 Apr; 35(4):197-201. PubMed ID: 16519765
[TBL] [Abstract][Full Text] [Related]
17. Roles of CYP1A1 and CYP2E1 Gene Polymorphisms in Oral Submucous Fibrosis.
Yaming P; Urs AB; Saxena A; Zuberi M
Asian Pac J Cancer Prev; 2016; 17(7):3335-40. PubMed ID: 27509973
[TBL] [Abstract][Full Text] [Related]
18. Molecular Pathology of Malignant Transformation of Oral Submucous Fibrosis.
Chattopadhyay A; Ray JG
J Environ Pathol Toxicol Oncol; 2016; 35(3):193-205. PubMed ID: 27910776
[TBL] [Abstract][Full Text] [Related]
19. Increased plasminogen activator inhibitor-1/tissue type plasminogen activator ratio in oral submucous fibrosis.
Yang SF; Hsieh YS; Tsai CH; Chen YJ; Chang YC
Oral Dis; 2007 Mar; 13(2):234-8. PubMed ID: 17305628
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of transforming growth factor beta1 gene in oral submucous fibrosis induced in Sprague-Dawley rats by injections of areca nut and pan masala (commercial areca nut product) extracts.
Maria S; Kamath VV; Satelur K; Rajkumar K
J Cancer Res Ther; 2016; 12(1):379-85. PubMed ID: 27072267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
